Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
- PMID: 33663644
- PMCID: PMC7934223
- DOI: 10.2807/1560-7917.ES.2021.26.9.2100133
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
Erratum in
-
Correction for Euro Surveill. 2020;26(9).Euro Surveill. 2021 Mar;26(10):210311c. doi: 10.2807/1560-7917.ES.2021.26.10.210311c. Euro Surveill. 2021. PMID: 33706860 Free PMC article. No abstract available.
Abstract
The emergence of SARS-CoV-2 variant 20I/501Y.V1 (VOC-202012/1 or GR/501Y.V1) is concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% of all positive tests) performed on 7-8 January 2021 in France. The prevalence of 20I/501Y.V1 was 3.3% among positive tests nationwide and 6.9% in the Paris region. Analysing the recent rise in the prevalence of 20I/501Y.V1, we estimate that, in the French context, 20I/501Y.V1 is 52-69% more transmissible than the previously circulating lineages, depending on modelling assumptions.
Keywords: 20I/501Y.V1; COVID; France; SARS-CoV-2; mutation; surveillance; viral infections.
Conflict of interest statement
Figures
References
-
- Volz Erik, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, et al. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. medRxiv. 2020.12.30.20249034. https://doi.org/10.1101/2020.12.30.20249034
-
- Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S, et al. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021;26(3):2100008. 10.2807/1560-7917.ES.2021.26.3.2100008 - DOI - PMC - PubMed
-
- Sante Publique France. COVID-19: point épidémiologique du 28 janvier 2021. [COVID-19: epidemiological update of 28 January 2021]. Paris: Santé Publique France; 2021. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-...
-
- Sante Publique France. COVID-19: point épidémiologique du 14 janvier 2021. [COVID-19: epidemiological update of 14 January 2021]. Paris: Santé Publique France; 2021. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-...
-
- Sante Publique France. COVID-19: point épidémiologique du 11 février 2021. [COVID-19: epidemiological update of 11 February 2021]. Paris: Santé Publique France; 2021. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-...
MeSH terms
LinkOut - more resources
Full Text Sources